NCT04937777: EMN 23 - Study on the Management & Outcome of Systemic AL Amyloidosis in Europe

• EMN 23

• NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

This is a retrospective, observational, multicenter study to collect Real-World Evidence (RWE) data on systemic AL-AMY patients in Europe. Data from paper/electronic medical records and/or electronic databases from key reference centers in Europe will be used. Data will either be entered by the site staff in the electronic Case Report Form (eCRF) or, where feasible, transferred directly, always in accordance to local regulations.

Sponsor

European Myeloma Network

---

ClinicalTrials.gov Identifier: NCT04937777

Official Title: A Retrospective Observational Multicenter Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

First Posted : June 24, 2021

Click here to see details on ClinicalTrials.gov

EMN23 - European Myeloma Network (myeloma-europe.org)

---

Locations

Europe

United Kingdom

Austria

Czechia

France

Germany

Greece

Italy

Netherlands

Portugal

Spain